CHANGES OF LIVER STIFFNESS AND SERUM MARKERS OF FIBROSIS IN LIVER TRANSPLANT RECIPIENTS WITH SVR FOLLOWING INTERFERON-FREE TREATMENT

被引：0
|
作者：
Iacob, Speranta [1 ]
Popescu, Irinel [1 ]
Gheorghe, Liana [1 ]
机构：
[1] Fundeni Clin Inst, Bucharest, Romania
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P225
引用
收藏
页码：450 / 450
页数：1
相关论文
共 50 条
  • [31] Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy
    Tanwar, Sudeep
    Trembling, Paul M.
    Hogan, Brian J.
    Srivastava, Ankur
    Parkes, Julie
    Harris, Scott
    Grant, Paul
    Nastouli, Eleni
    Ocker, Mathias
    Wehr, Klaus
    Herold, Christoph
    Neureiter, Daniel
    Schuppan, Detlef
    Rosenberg, William M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (03) : 289 - 296
  • [32] Interferon-free antiviral therapy for chronic hepatitis C among patients in the liver transplant setting
    van Tilborg, Marjolein
    Maan, Raoel
    van der Meer, Adriaan J.
    de Knegt, Robert J.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2017, 31 (02) : 219 - 225
  • [33] Fibrosis progression in HCV positive liver transplant recipients treated or untreated with interferon-α.
    Trunecka, Pavel
    Honsova, Eva
    Hackajlo, David
    Frankova, Sona
    Reznakova, Sona
    Sperl, Jan
    Adamec, Milos
    Lanska, Vera
    Spicak, Julius
    Vitko, Stefan
    LIVER TRANSPLANTATION, 2007, 13 (06) : S150 - S151
  • [34] Effect of Interferon On Fibrosis Progression Among Liver Transplant Recipients With Hepatitis C.
    Habib, S.
    Meister, E.
    Rana, A.
    Obaid, S.
    TRANSPLANTATION, 2014, 98 : 708 - 708
  • [35] Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit
    Colli, Agostino
    Fraquelli, Mirella
    Prati, Daniele
    Riva, Alessia
    Berzuini, Alessandra
    Conte, Dario
    Aghemo, Alessio
    Colombo, Massimo
    Casazza, Giovanni
    PLOS ONE, 2016, 11 (10):
  • [36] Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients
    Fernandez-Alvarez, Paula
    Guerra-Veloz, Maria Fernanda
    Vilches-Arenas, Angel
    Cordero-Ruiz, Patricia
    Bellido-Munoz, Francisco
    Caunedo-Alvarez, Angel
    Carmona-Soria, Isabel
    VIRUSES-BASEL, 2023, 15 (06):
  • [37] Effects of interferon-free treatment on chronic hepatitis C patients with autoimmune liver diseases
    Kanda, Tatsuo
    Nakamura, Masato
    Yasui, Shin
    Arai, Makoto
    Nakamoto, Shingo
    Chiba, Tetsuhiro
    Maruyama, Hitoshi
    Moriyama, Mitsuhiko
    Kato, Naoya
    HEPATOLOGY, 2017, 66 : 197A - 198A
  • [38] Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease
    Krawczyk, Marcin
    Zimmermann, Simone
    Hess, Georg
    Holz, Robert
    Dauer, Marc
    Raedle, Jochen
    Lammert, Frank
    Gruenhage, Frank
    PLOS ONE, 2017, 12 (03):
  • [39] Outcomes of liver transplant recipients with hepatitis C receiving interferon/ribavirin treatment
    Smallwood, GA
    Devine, R
    Lehneman, J
    Connor, K
    Stieber, AC
    Heffron, TG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 500 - 500
  • [40] Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant
    Herzer, Kerstin
    Papadopoulos-Koehn, Angela
    Walker, Andreas
    Achterfeld, Anne
    Paul, Andreas
    Canbay, Ali
    Timm, Joerg
    Gerken, Guido
    DIGESTION, 2015, 91 (04) : 326 - 333
12345